299 filings
6-K
IMRN
Immuron Limited
3 May 24
Report of Foreign Private Issuer
8:00am
6-K
IMRN
Immuron Limited
23 Apr 24
Report of Foreign Private Issuer
6:06am
6-K
IMRN
Immuron Limited
15 Apr 24
Report of Foreign Private Issuer
8:00am
6-K
IMRN
Immuron Limited
10 Apr 24
Immuron Travelan® sales continued strong growth
6:14am
6-K
IMRN
Immuron Limited
14 Mar 24
Report of Foreign Private Issuer
6:50am
6-K
IMRN
Immuron Limited
7 Mar 24
Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
8:00am
6-K
IMRN
Immuron Limited
4 Mar 24
Report of Foreign Private Issuer
9:19pm
6-K
IMRN
Immuron Limited
28 Feb 24
Results for announcement to the market
8:08am
6-K
IMRN
Immuron Limited
21 Feb 24
Report of Foreign Private Issuer
8:00am
6-K
IMRN
Immuron Limited
13 Feb 24
Immuron achieves record Travelan® sales
8:00am
6-K
IMRN
Immuron Limited
9 Feb 24
Investor Webinar Presentation
12:00am
6-K
IMRN
Immuron Limited
16 Jan 24
Immuron achieves record half yearly Travelan® sales
8:00am
6-K
IMRN
Immuron Limited
22 Dec 23
Immuron Clinical Trials Update
7:21am
6-K
IMRN
Immuron Limited
4 Dec 23
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
6:32am
6-K
IMRN
Immuron Limited
28 Nov 23
Investor Webinar Presentation
6:17am
6-K
IMRN
Immuron Limited
22 Nov 23
Report of Foreign Private Issuer
7:16am
6-K
IMRN
Immuron Limited
21 Nov 23
Report of Foreign Private Issuer
6:05am
6-K
IMRN
Immuron Limited
13 Nov 23
Investor Webinar Presentation
8:28am
6-K
IMRN
Immuron Limited
30 Oct 23
Immuron CEO, Steven Lydeamore to present at AusBioInvest
8:00am
6-K
IMRN
Immuron Limited
23 Oct 23
Notice of 2023 Annual General Meeting and 21 November 2023 at 10.00 am
8:00am